We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correlation between Computed Tomography and Pathological Findings of Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate.
- Authors
Ki Choon Sim; Beom Jin Park; Na Yeon Han; Deuk Jae Sung; Min Ju Kim; Sung Bum Cho; Hyun Kwon Ha; Hyoung Rae Kim
- Abstract
Purpose: To evaluate the correlation between pathological and computed tomography (CT) findings of gastrointestinal stromal tumors (GISTs) after imatinib mesylate (imatinib) treatment. Materials and Methods: Twenty-six patients with GIST (17 men, 9 women; mean age, 56 years) who underwent treatment with imatinib and who were registered at our institution were included. Eight patients had primary and 18 had metastatic tumors. The correlation between CT and pathological findings was evaluated for all 26 tumors, which were resected after imatinib treatment. Results: The mean size change in the tumors after imatinib treatment was -1.4 cm (range, -7.8-2.5 cm). A reduction in tumor CT attenuation value was observed after imatinib treatment (mean, 29.1 Hounsfield units) in 20 of 26 tumors. Reduced attenuation was associated with non-tumorous pathological findings, including cystic degeneration (6/20), hemorrhagic necrosis (6/20), hyaline degeneration (6/20), and combined pathology without a viable portion (2/20). Of six tumors showing increased attenuation values after treatment, four (66.7%) showed an abundant viable portion. The increase in tumor size was not associated with the presence of a viable portion in any tumor. Conclusion: CT attenuation changes in GISTs may adequately reflect the pathological findings in GISTs after imatinib treatment.
- Subjects
GASTROINTESTINAL stromal tumors; DRUG therapy; IMATINIB; COMPUTED tomography; PATHOLOGY; TUMOR treatment
- Publication
Journal of the Korean Society of Radiology, 2014, Vol 71, Issue 5, p239
- ISSN
1738-2637
- Publication type
Article
- DOI
10.3348/jksr.2014.71.5.239